NCT00910923
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
157 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00783744
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi aventis administrative office Vienna, Austria
- Sanofi-aventis administrative office Helsinki, Finland
- Sanofi-aventis administrative office Paris, France
- Sanofi-Aventis Administrative Office Berlin, Germany
NCT00519142
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Elixir Study Site Glendale, Arizona, United States
- Elixir Study Site Greenbrae, California, United States
- Elixir Study Site La Jolla, California, United States
- Elixir Study Site Los Angeles, California, United States
Completed
Lantus Versus Levemir Treat-To-Target
NCT00405418
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis North Ryde, Australia
- Sanofi-Aventis São Paulo, Brazil
- Sanofi-Aventis Laval, Canada
- Sanofi-Aventis Hoersholm, Denmark
NCT00174642
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis Brussels, Belgium
- Sanofi-Aventis Paris, France
- Sanofi-Aventis Berlin, Germany
- Sanofi-Aventis Athens, Greece
NCT00347100
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis Beijing, China
NCT00174668
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis North Ryde, Australia
- Sanofi-Aventis Brussels, Belgium
- Sanofi-Aventis Prague, Czechia
- Sanofi-Aventis Paris, France
NCT00841919
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- John H Stroger Jr. Hospital Chicago, Illinois, United States
NCT00290927
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
NCT00638313
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site San Antonio, Texas, United States